Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$224.73 - $338.64 $3.15 Million - $4.74 Million
-14,000 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$277.25 - $366.29 $3.88 Million - $5.13 Million
14,000 New
14,000 $4.64 Million
Q3 2021

Nov 15, 2021

SELL
$310.19 - $376.2 $12.1 Million - $14.7 Million
-39,000 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$262.71 - $351.17 $10.2 Million - $13.7 Million
39,000 New
39,000 $12.2 Million

Others Institutions Holding ABMD

About ABIOMED INC


  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.